The British Journal of Psychiatry (2007) 191: s71-s77. doi: 10.1192/bjp.191.50.s71
© 2007 The Royal College of Psychiatrists
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit an eLetter
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Isaac, M.
Right arrow Articles by Murthy, P.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Isaac, M.
Right arrow Articles by Murthy, P.

REVIEW ARTICLES

Schizophrenia outcome measures in the wider international community

Mohan Isaac, MD, DPM, FRCPsych

Community, Culture and Mental Health Unit, School of Psychiatry and Clinical Neurosciences, University of Western Australia, Fremantle, WA 6160, Australia

Prabhat Chand, MD, DNB and Pratima Murthy, MD, DPM

Department of Psychiatry, National Institute of Mental Health and Neurosciences, Bangalore, India

Correspondence: Dr Mohan Isaac, Community, Culture and Mental Health Unit, School of Psychiatry and Clinical Neurosciences, University of Western Australia, 16 The Terrace, Fremantle, WA 6160, Australia. Email: Mohan.Isaac{at}uwa.edu.au

Declaration of interest None.

Background Outcome of schizophrenia has been described as favourable in low- and middle-income countries. Recently, researchers have questioned these findings.

Aims To examine the outcome studies carried out in different countries specifically looking at those from low- and middle-income countries.

Methods Long-term course and outcome studies in schizophrenia were reviewed.

Results A wide variety of outcome measures are used. The most frequent are clinical symptoms, hospitalisation and mortality (direct indicators), and social/occupational functioning, marriage, social support and burden of care (indirect indicators). Areas such as cognitive function, duration of untreated psychosis, quality of life and effect of medication have not been widely studied in low- and middle-income countries.

Conclusions The outcome of schizophrenia appears to be better in low- and middle-income countries. A host of sociocultural factors have been cited as contributing to this but future research should aim to understand this better outcome. There is a need for more culture-specific instruments to measure outcomes.




This article has been cited by other articles:


Home page
 Br. J. PsychiatryHome page
P. Tyrer
From the Editor's desk
The British Journal of Psychiatry, November 1, 2008; 193(5): 434 - 434.
[Full Text] [PDF]

Home page
 Schizophr BullHome page
A. Cohen, V. Patel, R. Thara, and O. Gureje
Questioning an Axiom: Better Prognosis for Schizophrenia in the Developing World?
Schizophr Bull, March 1, 2008; 34(2): 229 - 244.
[Abstract] [Full Text] [PDF]

Home page
 Br. J. PsychiatryHome page
T. Burns
Evolution of outcome measures in schizophrenia
The British Journal of Psychiatry, August 1, 2007; 191(50): s1 - s6.
[Abstract] [Full Text] [PDF]